Literature DB >> 17567691

Ebola virus VP30 is an RNA binding protein.

Sinu P John1, Tan Wang, Scott Steffen, Sonia Longhi, Connie S Schmaljohn, Colleen B Jonsson.   

Abstract

The Ebola virus (EBOV) genome encodes for several proteins that are necessary and sufficient for replication and transcription of the viral RNAs in vitro; NP, VP30, VP35, and L. VP30 acts in trans with an RNA secondary structure upstream of the first transcriptional start site to modulate transcription. Using a bioinformatics approach, we identified a region within the N terminus of VP30 with sequence features that typify intrinsically disordered regions and a putative RNA binding site. To experimentally assess the ability of VP30 to directly interact with the viral RNA, we purified recombinant EBOV VP30 to >90% homogeneity and assessed RNA binding by UV cross-linking and filter-binding assays. VP30 is a strongly acidophilic protein; RNA binding became stronger as pH was decreased. Zn(2+), but not Mg(2+), enhanced activity. Enhancement of transcription by VP30 requires a RNA stem-loop located within nucleotides 54 to 80 of the leader region. VP30 showed low binding affinity to the predicted stem-loop alone or to double-stranded RNA but showed a good binding affinity for the stem-loop when placed in the context of upstream and downstream sequences. To map the region responsible for interacting with RNA, we constructed, purified, and assayed a series of N-terminal deletion mutations of VP30 for RNA binding. The key amino acids supporting RNA binding activity map to residues 26 to 40, a region rich in arginine. Thus, we show for the first time the direct interaction of EBOV VP30 with RNA and the importance of the N-terminal region for binding RNA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17567691      PMCID: PMC1951390          DOI: 10.1128/JVI.02523-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  The PSIPRED protein structure prediction server.

Authors:  L J McGuffin; K Bryson; D T Jones
Journal:  Bioinformatics       Date:  2000-04       Impact factor: 6.937

2.  Purification and characterization of the Sin Nombre virus nucleocapsid protein expressed in Escherichia coli.

Authors:  C B Jonsson; J Gallegos; P Ferro; W Severson; X Xu; C S Schmaljohn; P Fero
Journal:  Protein Expr Purif       Date:  2001-10       Impact factor: 1.650

3.  VaZyMolO: a tool to define and classify modularity in viral proteins.

Authors:  François Ferron; Corinne Rancurel; Sonia Longhi; Christian Cambillau; Bernard Henrissat; Bruno Canard
Journal:  J Gen Virol       Date:  2005-03       Impact factor: 3.891

4.  Descriptive analysis of Ebola virus proteins.

Authors:  L H Elliott; M P Kiley; J B McCormick
Journal:  Virology       Date:  1985-11       Impact factor: 3.616

5.  Characterization of the Hantaan nucleocapsid protein-ribonucleic acid interaction.

Authors:  W Severson; L Partin; C S Schmaljohn; C B Jonsson
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

6.  Functional identification of nucleotides conferring substrate specificity to retroviral integrase reactions.

Authors:  M Balakrishnan; C B Jonsson
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

7.  The intracellular domain of the Drosophila cholinesterase-like neural adhesion protein, gliotactin, is natively unfolded.

Authors:  Tzviya Zeev-Ben-Mordehai; Edwin H Rydberg; Ariel Solomon; Lilly Toker; Vanessa J Auld; Israel Silman; Simone Botti; Joel L Sussman
Journal:  Proteins       Date:  2003-11-15

8.  Phosphorylation of VP30 impairs ebola virus transcription.

Authors:  Jens Modrof; Elke Mühlberger; Hans-Dieter Klenk; Stephan Becker
Journal:  J Biol Chem       Date:  2002-06-06       Impact factor: 5.157

9.  Protein disorder prediction: implications for structural proteomics.

Authors:  Rune Linding; Lars Juhl Jensen; Francesca Diella; Peer Bork; Toby J Gibson; Robert B Russell
Journal:  Structure       Date:  2003-11       Impact factor: 5.006

10.  Biophysical characterization of the complex between double-stranded RNA and the N-terminal domain of the NS1 protein from influenza A virus: evidence for a novel RNA-binding mode.

Authors:  Chen-ya Chien; Yujia Xu; Rong Xiao; James M Aramini; Parag V Sahasrabudhe; Robert M Krug; Gaetano T Montelione
Journal:  Biochemistry       Date:  2004-02-24       Impact factor: 3.162

View more
  24 in total

1.  RNA Binding of Ebola Virus VP30 Is Essential for Activating Viral Transcription.

Authors:  Nadine Biedenkopf; Julia Schlereth; Arnold Grünweller; Stephan Becker; Roland K Hartmann
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

2.  Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway.

Authors:  Giulia Fabozzi; Christopher S Nabel; Michael A Dolan; Nancy J Sullivan
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

3.  How disordered is my protein and what is its disorder for? A guide through the "dark side" of the protein universe.

Authors:  Philippe Lieutaud; François Ferron; Alexey V Uversky; Lukasz Kurgan; Vladimir N Uversky; Sonia Longhi
Journal:  Intrinsically Disord Proteins       Date:  2016-12-21

4.  Phosphorylation of Ebola virus VP30 influences the composition of the viral nucleocapsid complex: impact on viral transcription and replication.

Authors:  Nadine Biedenkopf; Bettina Hartlieb; Thomas Hoenen; Stephan Becker
Journal:  J Biol Chem       Date:  2013-03-14       Impact factor: 5.157

5.  Predicting Protein Conformational Disorder and Disordered Binding Sites.

Authors:  Ketty C Tamburrini; Giulia Pesce; Juliet Nilsson; Frank Gondelaud; Andrey V Kajava; Jean-Guy Berrin; Sonia Longhi
Journal:  Methods Mol Biol       Date:  2022

6.  Role of Ebola virus VP30 in transcription reinitiation.

Authors:  Miguel J Martínez; Nadine Biedenkopf; Valentina Volchkova; Bettina Hartlieb; Nathalie Alazard-Dany; Olivier Reynard; Stephan Becker; Viktor Volchkov
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

7.  The respiratory syncytial virus M2-1 protein forms tetramers and interacts with RNA and P in a competitive manner.

Authors:  Thi-Lan Tran; Nathalie Castagné; Virginie Dubosclard; Sylvie Noinville; Emmanuelle Koch; Mohammed Moudjou; Céline Henry; Julie Bernard; Robert Paul Yeo; Jean-François Eléouët
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

8.  The marburg virus 3' noncoding region structurally and functionally differs from that of ebola virus.

Authors:  Sven Enterlein; Kristina M Schmidt; Michael Schümann; Dominik Conrad; Verena Krähling; Judith Olejnik; Elke Mühlberger
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

9.  RNA binding specificity of Ebola virus transcription factor VP30.

Authors:  Julia Schlereth; Arnold Grünweller; Nadine Biedenkopf; Stephan Becker; Roland K Hartmann
Journal:  RNA Biol       Date:  2016-06-17       Impact factor: 4.652

Review 10.  Distinct Genome Replication and Transcription Strategies within the Growing Filovirus Family.

Authors:  Adam J Hume; Elke Mühlberger
Journal:  J Mol Biol       Date:  2019-06-29       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.